We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$230B
AUM Growth
+$18.4B
Cap. Flow
-$8.18B
Cap. Flow %
-3.55%
Top 10 Hldgs %
23.04%
Holding
10,299
New
1,220
Increased
3,476
Reduced
4,117
Closed
1,265

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$615M
2
UBER icon
Uber
UBER
+$551M
3
EXPE icon
Expedia Group
EXPE
+$523M
4
PYPL icon
PayPal
PYPL
+$452M
5
ETN icon
Eaton
ETN
+$408M

Sector Composition

Rank Sector Weight
1 Technology 5.29%
2 Financials 4.55%
3 Industrials 4.18%
4 Healthcare 4.08%
5 Consumer Discretionary 3.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BVN icon
6651
PUT
Compañía de Minas Buenaventura
BVN
$8.57B
$488K ﹤0.01%
+32,300
New +$479K
FISI icon
6652
Financial Institutions
FISI
$823M
$488K ﹤0.01%
15,198
+1,481
+11% +$46.7K
IWC icon
6653
CALL
iShares Micro-Cap ETF
IWC
$1.52B
$488K ﹤0.01%
4,900
+1,600
+48% +$148K
QDEL icon
6654
CALL
QuidelOrtho
QDEL
$981M
$488K ﹤0.01%
6,500
+2,900
+81% +$187K
ASND icon
6655
PUT
Ascendis Pharma A/S
ASND
$16.3B
$487K ﹤0.01%
3,500
-8,200
-70% -$911K
DGICA icon
6656
Donegal Group Class A
DGICA
$696M
$487K ﹤0.01%
32,838
+2,828
+9% +$41.4K
GVA icon
6657
PUT
Granite Construction
GVA
$5.56B
$487K ﹤0.01%
+17,600
New +$501K
RVNC
6658
DELISTED
Revance Therapeutics, Inc.
RVNC
$487K ﹤0.01%
30,036
-132,716
-82% -$2.06M
AMK
6659
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$487K ﹤0.01%
16,800
-73,022
-81% -$1.91M
MBT
6660
CALL
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$487K ﹤0.01%
48,000
-12,600
-21% -$115K
BLMN icon
6661
CALL
Bloomin' Brands
BLMN
$903M
$486K ﹤0.01%
22,000
-9,600
-30% -$204K
NOVT icon
6662
CALL
Novanta
NOVT
$6.3B
$486K ﹤0.01%
5,500
+1,300
+31% +$112K
ZYME icon
6663
PUT
Zymeworks
ZYME
$1.78B
$486K ﹤0.01%
+10,700
New +$389K
FLEX icon
6664
PUT
Flex
FLEX
$46.6B
$485K ﹤0.01%
50,957
-46,047
-47% -$397K
LNN icon
6665
Lindsay Corp
LNN
$1.17B
$485K ﹤0.01%
+5,048
New +$461K
NTRA icon
6666
CALL
Natera
NTRA
$44.7B
$485K ﹤0.01%
14,400
-6,700
-32% -$247K
COHR
6667
DELISTED
Coherent Inc
COHR
$485K ﹤0.01%
+2,917
New +$452K
LM
6668
PUT
DELISTED
Legg Mason, Inc.
LM
$485K ﹤0.01%
13,500
-23,200
-63% -$861K
HXL icon
6669
PUT
Hexcel
HXL
$7.87B
$484K ﹤0.01%
6,600
-53,500
-89% -$4.11M
WVE icon
6670
Wave Life Sciences
WVE
$1.07B
$484K ﹤0.01%
60,404
-13,838
-19% -$339K
QTTB icon
6671
Q32 Bio
QTTB
$451M
$484K ﹤0.01%
1,299
-39,430
-97% -$11.3M
POLY
6672
PUT
DELISTED
Plantronics, Inc.
POLY
$484K ﹤0.01%
+17,700
New +$533K
OILD
6673
DELISTED
ProShares UltraPro 3x Short Crude Oil ETF
OILD
$484K ﹤0.01%
+45,766
New +$646K
ADVM
6674
CALL
DELISTED
Adverum Biotechnologies
ADVM
$483K ﹤0.01%
4,190
-10,400
-71% -$917K
AMG icon
6675
CALL
Affiliated Managers Group
AMG
$9.89B
$483K ﹤0.01%
5,700
-11,500
-67% -$943K

Similar funds

Ken Griffin's Q4 2019 Portfolio in Review

As of Q4 2019, Ken Griffin held 10,299 positions worth $230B, up 8.7% from $212B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ken Griffin withdrew a net $8.18B in Q4 2019, closing 1,265 positions and reducing 4,117 holdings. Its most notable exit was Celgene Corp, an estimated $681M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.3% of assets, down from 5.4% a quarter earlier, followed by Financials and Industrials.

Against the trend, Ken Griffin opened a new position in Interxion Holding N.V. worth $83.9M.

  • Ken Griffin's largest Q4 2019 buy was Interxion Holding N.V.: 1,000,931 shares worth $83.9M.
  • Ken Griffin added most to Amazon in Q4 2019, an estimated $615M increase.
  • Ken Griffin's biggest Q4 2019 reduction was Raytheon Company, cutting an estimated $543M.
  • Ken Griffin fully exited Celgene Corp in Q4 2019, selling an estimated $681M.
  • Ken Griffin's ten largest holdings make up 23% of its $230B portfolio in Q4 2019.
  • Ken Griffin opened 1,220 new positions and closed 1,265 in Q4 2019.
  • Ken Griffin's portfolio value rose 8.7% quarter-over-quarter to $230B.

Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.